Verve Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Verve Therapeutics Inc
TickerVERV
CIK #0001840574
CUSIP92539P101
SectorLife Sciences - Pharmaceutical Preparations
Address500 Technology Square, Cambridge, MA 02139
Source [EDGAR]
CIK Filing 2011 - 2024
[0001840574] 10-K
[0001840574] 10-Q
[0001840574] 3
[0001840574] 4
[0001840574] 8-K
[0001840574] D
[0001840574] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
ARK Investment Management LLC Verve Therapeutics Inc [2023-02-10] 7.09
BlackRock Inc Verve Therapeutics Inc [2023-02-10] 5.8
Vanguard Group Inc Verve Therapeutics Inc [2023-02-09] 6.19
State Street Corp Verve Therapeutics Inc [2023-02-07] 7.26
GV 2017 LP Verve Therapeutics Inc [2022-02-14] 13.12
Arch Venture Fund X LP Verve Therapeutics Inc [2022-02-09] 5.2
Wellington Management Group LLP Verve Therapeutics Inc [2022-02-04] 8.18
Singer James R Verve Therapeutics Inc [2022-01-24] 5.1
Wellington Biomedical Innovation Master Investors Cayman I LP Verve Therapeutics Inc [2021-06-28] 5.18
Casdin Capital LLC Verve Therapeutics Inc [2021-06-23] 6.6
FMR LLC Verve Therapeutics Inc [2021-06-23] 0.0
Form 3/4/5 Filer 2011 - 2024
Nickerson Joan
Verve Therapeutics, Inc.
Dorval Allison
Bellinger Andrew
Ashe Andrew D.
MacLean Michael F
Kathiresan Sekar
GV 2019 GP LP
GV 2019 GP LLC
Alphabet Inc.
GV 2017 GP LLC
GV 2017 LP
GV 2017 GP LP
GV 2019 LP
Yeshwant Krishna
Coats Lonnel
FMR LLC
Cumbo Alexander
Mikhail Sheila
Evans John M.
Adelman Burt A
Green Jeremy
Redmile Group, LLC
Chen Bihua
Cormorant Private Healthcare Fund III LP
Cormorant Global Healthcare Master Fund, LP
Cormorant Asset Management, LP
ARCH Venture Partners X, LLC
Crandell Keith
ARCH Venture Partners X, L.P.
Nelsen Robert
ARCH Venture Fund X Overage, L.P.
Burow Kristina
ARCH Venture Fund X, L.P.
Gillis Steven
ARCH Venture Partners X Overage, L.P.
Beam Therapeutics Inc.
Broad Institute, Inc.
Rock Springs Capital Master Fund LP
Rock Springs Capital LLC
Rock Springs Capital Management LP
Wellington Biomedical Innovation Master Investors (Cayman) I
Casdin Partners Master Fund, L.P.
Novo Holdings A/S
Casdin Private Growth Equity Fund, L.P.
Logos Global Management LP
Beaudoin Margaret
Biomatics Capital Partners, L.P.
Joung Jae Keith
Rozen Israel
Ticho Barry
Form 13F Holdings
Firm Period DFND Voting Shares
Alphabet Inc. [2023-03-31] DFND 0.0 10,549,086.0
FMR LLC [2023-03-31] DFND 6,741,675.0 6,826,817.0
ARK Investment Management LLC [2023-03-31] SOLE 4,385,803.0 4,482,091.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 3,810,569.0
BlackRock Inc. [2023-03-31] SOLE 3,466,777.0 3,546,485.0
State Street Corp [2023-03-31] DFND 3,263,689.0 3,349,777.0
Federated Hermes Inc [2023-03-31] DFND 2,402,640.0 2,402,640.0
Casdin Capital LLC [2023-03-31] SOLE 2,120,571.0 2,120,571.0
Arch Venture Management LLC [2023-03-31] SOLE 0.0 2,008,809.0
T. Rowe Price Investment Management, Inc. [2023-03-31] SOLE 731,860.0 2,006,127.0
JPMorgan Chase & Co [2023-03-31] DFND 1,701,464.0 1,908,364.0
Nikko Asset Management Americas Inc [2023-03-31] SOLE 1,193,396.0 1,597,994.0
Sumitomo Mitsui Trust Holdings, Inc. [2023-03-31] DFND 1,597,994.0 1,597,994.0
Baker Bros Advisors LP [2023-03-31] SOLE 1,416,530.0 1,416,530.0
Avidity Partners Management LP [2023-03-31] SOLE 1,351,700.0 1,351,700.0
Novo Holdings A/S [2023-03-31] SOLE 1,200,000.0 1,200,000.0
Redmile Group LLC [2023-03-31] SOLE 1,120,679.0 1,120,679.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 933,167.0
Geode Capital Management LLC [2023-03-31] DFND 885,771.0 885,771.0
Bioimpact Capital LLC [2023-03-31] SOLE 803,501.0 803,501.0
BVF Inc/IL [2023-03-31] DFND 0.0 650,000.0
Rock Springs Capital Management LP [2023-03-31] SOLE 558,837.0 558,837.0
Citigroup Inc [2023-03-31] DFND 494,019.0 494,019.0
Citadel Advisors LLC [2023-03-31] DFND 434,662.0 434,662.0
Northern Trust Corp [2023-03-31] DFND 18,317.0 403,025.0
Woodline Partners LP [2023-03-31] SOLE 386,466.0 386,466.0
Bank of America Corp /DE/ [2023-03-31] DFND 9,336.0 384,706.0
Cormorant Asset Management LP [2023-03-31] DFND 350,000.0 350,000.0
Hood River Capital Management LLC [2023-03-31] SOLE 319,314.0 344,776.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 322,300.0 322,300.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com